| CPC A61K 31/404 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 31/16 (2013.01); A61K 31/167 (2013.01); A61K 31/24 (2013.01); A61K 31/245 (2013.01); A61K 31/381 (2013.01); A61K 31/405 (2013.01); A61K 31/445 (2013.01); A61K 31/541 (2013.01); A61K 38/57 (2013.01); A61K 39/39533 (2013.01); A61K 45/06 (2013.01); C07K 16/18 (2013.01); C07K 2317/55 (2013.01); Y02A 50/30 (2018.01)] | 5 Claims |
|
1. A method of treating a patient or subject suffering from envenomation by a snake comprising administering to said patient or subject, a therapeutically effective amount of a PLA2 inhibitor selected from the group consisting of varespladib, methylvarespladib, a pharmaceutically acceptable salt thereof, or a combination thereof, in combination with a pharmaceutically acceptable carrier, additive or excipient and at least one additional agent selected from the group consisting of a metalloproteinase inhibitor, a snake antivenom or a mixture thereof.
|